RxDoctor Payments Data

Kathryn Tyler

Physician Assistant · Mission Viejo, CANPI 1629633789

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,390 of the $76,966 with a category attached, or 70.7%. Atricure, Inc. accounts for 79.2% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2023 at $37,058 and has fallen 87.3% since, to $4,694 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,966in general payments, 2019–2025

Across 421 payments — averaging $182.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$61K
  • Merit Medical Systems Inc$3K
  • Abbott$2K
  • Abiomed$2K
  • Boston Scientific$1K
  • Novartis$991
  • plus $7K from 30 others

What the payments were for

  • Consulting fees$54,39071%
  • Travel & lodging$7,2299%
  • Food & beverage$15,29720%
  • Education$500%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,966 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban293$342,159
EntrestoSacubitril/Valsartan89$125,474
XareltoRivaroxaban74$88,278
MultaqDronedarone Hcl45$63,795
JardianceEmpagliflozin23$22,713
Repatha SureclickEvolocumab27$17,003
VerquvoVericiguat14$14,151
Metoprolol Succinate219$3,180
EdarbiAzilsartan Medoxomil12$3,028
Sotalol AfSotalol Hcl85$2,289
Valsartan112$2,205
Atorvastatin Calcium185$2,022
Amiodarone Hcl85$1,968
Flecainide Acetate48$1,877
Losartan Potassium194$1,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$377$342,159293 claims
NovartisEntresto$991$125,47489 claims
Johnson & JohnsonXarelto$28$88,27874 claims
Sanofi-aventis U.S. LLCMultaq$366$63,79545 claims
Boehringer IngelheimJardiance$585$22,71323 claims
MerckVerquvo$300$14,15114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Mission Viejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →